1例冠状动脉支架内血栓再形成病例报道
A Case of Coronary Stent Thrombosis Reformation Is Reported

DOI: 10.12677/ACRVM.2019.73008, PP. 47-49

Keywords: 冠状动脉支架内血栓形成，病例报道，危险因素
Coronary Stent Thrombosis, Case Reports, Risk Factors

Full-Text   Cite this paper   Add to My Lib

Abstract:

冠状动脉粥样硬化性心脏病(Coronary Atherosclerotic Heart Disease)指冠状动脉发生动脉粥样硬化病变引起血管腔狭窄或阻塞，造成心肌缺血、缺氧或坏死而导致的心脏病，简称冠心病，是威胁人类健康的主要疾病之一。现经皮冠状动脉介入治疗(PCI)是目前冠心病治疗的重要手段，支架内血栓再形成是PCI术治疗过程中罕见但极其危重的并发症。相关研究表明与金属裸支架(baremetalstent, BMS)相比，药物涂层支架(drug-elutingstents，DES)的出现大大降低了支架内血栓再形成发生率，从很大程度上提高冠心病患者的疗效和改善其预后，降至10%以下。相关研究表明ISR的发生是由多种因素造成的，包括个体因素、病变因素、支架选择等因素。术前若能充分的了解并评估ISR的危险因素，可在一定程度上改善冠心病患者临床症状及远期预后。本文将报道1例冠状动脉支架内血栓再形成病例及简述支架危险因素，为降低ISR发生率提供一定参考价值。
Coronary atherosclerotic heart disease (coronary atherosclerotic heart diseases) refers to coronary artery atherosclerosis lesions which cause vascular cavity stenosis or occlusion, cause myocardial ischemia, hypoxia or necrosis caused by heart disease, which is one of the main diseases that threaten human health. Currently, percutaneous coronary intervention (PCI) is an important means for the treatment of coronary artery disease, and in-stent restenosis (ISR) is a rare but extremely critical complication during PCI. Studies have shown that drug-coated stents (DES) significantly reduce ISR incidence compared to BMS, significantly improve outcomes and outcomes in patients with coronary artery disease to less than 10%. Relevant studies have shown that ISR is caused by many factors, including individual factors, pathological factors, stent selection and other factors. If risk factors of ISR can be fully understood and evaluated before operation, clinical symptoms and long-term prognosis of CHD patients can be improved to a certain extent. This paper will report a case of coronary stent restenosis and summarize the risk factors of stent, so as to provide some relevant value for reducing the incidence of ISR.

References

[1]	Mei, C., Yuan, J., Li, F., et al. (2019) Efficient Spectral Compression of Wavelength-Shifting Soliton and Its Application in Integratable All-Optical Quantization. IEEE Photonics Journal, 11, Article No. 6100715. https://doi.org/10.1109/JPHOT.2018.2890424
[2]	蒯铮, 樊冰, 卜丽萍, 等. 冠状动脉支架内再狭窄的危险因素分析[J]. 中国临床医学, 2008, 15(5): 585-587.
[3]	朱玮玮, 赵林, 郭成军, 等. 再次置入药物洗脱支架治疗经皮冠状动脉支架置入术后早期与晚期支架内再狭窄的对比研究[J]. 中国医药, 2014, 9(2): 156-159.
[4]	张燕, 任艺虹, 周超飞, 等. 经皮冠状动脉介入治疗术后急性、亚急性支架内血栓形成的危险因素分析[J]. 中国循环杂志, 2013, 28(1): 17-20.
[5]	杜发旺. 冠状动脉支架内血栓形成患者的危险因素及预后[J]. 介入放射学杂志, 2016, 25(2): 160-163.
[6]	Saleh, A., Hammoudeh, A., Tabbalat, R., et al. (2016) Incidence and Prognosis of Stent Throm-bosis Following Percutaneous Coronary Intervention in Middle Eastern Patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1). Annals of Saudi Medicine, 36, 17-22. https://doi.org/10.5144/0256-4947.2016.17
[7]	Li, M., Li, K., Qi, X., et al. (2016) Percutaneous Transhepatic Biliary Stent Implantation for Obstructive Jaundice of Perihilar Cholangiocarcinoma: A Prospective Study on Predictors of Stent Patency and Survival in 92 Patients. Journal of Vascular & Interventional Radiology, 27, 1047-1055. https://doi.org/10.1016/j.jvir.2016.02.035

Full-Text